Peppermint Oil May Lower Blood Pressure, New Study Finds
Adults diagnosed with prehypertension or stage 1 hypertension who consumed a small daily dose of peppermint oil twice daily for 20 days experienced an average systolic blood pressure reduction of 8.5 mmHg, according to findings published in PLOS One by researchers at the University of Lancashire. The placebo-controlled trial, which evaluated 40 participants aged 18 to 65, points to a potential low-cost adjunct intervention for vascular health, though clinical validation remains ongoing.
- Participants who received 100 microliters of peppermint oil twice daily experienced an average 8.5 mmHg drop in systolic blood pressure over 20 days.
- The study, led by researchers at the University of Lancashire and published in PLOS One, enrolled 40 participants with prehypertension or stage 1 hypertension.
- Investigators monitored secondary metrics including diastolic blood pressure, heart rate, body measurements, sleep quality, and mental well-being alongside primary vascular outcomes.
Clinical Trial Design and Patient Demographics
The study, which tracked 40 adult participants between the ages of 18 and 65, aimed to evaluate the physiological effects of botanical compounds on vascular resistance. Investigators enrolled individuals classified with prehypertension or stage 1 hypertension, assigning them randomly to two distinct cohorts. The intervention group received a precise daily dose of 100 microliters of peppermint oil, while the control group was administered a peppermint-flavored placebo lacking the active botanical components.
Led by Dr. Jonnie Sinclair, Reader in Sport and Health Sciences at the University of Lancashire, the research team sought to explore whether natural compounds could address elevated blood pressure without the adverse events often linked to conventional pharmaceuticals. Dr. Sinclair noted that while standard medications are widely prescribed for arterial hypertension, long-term adherence can be challenging due to unwanted side effects and uncertain efficacy profiles over extended periods.
Biological Mechanisms and Secondary Health Metrics
Peppermint naturally contains bioactive constituents, including menthol and various flavonoids, which have been hypothesized to influence vascular tone and endothelial function. Beyond tracking systolic blood pressure as the primary endpoint, the research team gathered data on multiple secondary health indicators. These measures included diastolic blood pressure readings, heart rate monitoring, anthropometric body measurements, blood test results, self-reported sleep quality metrics, and general mental well-being assessments.
Arterial hypertension remains a primary preventable risk factor for cardiometabolic disease and stands as the single greatest risk factor for global mortality. Given that conventional antihypertensive regimens can impose substantial financial burdens on healthcare systems, researchers emphasize the clinical significance of identifying safe, low-calorie, and economical interventions.
Future Trajectory and Regulatory Context
*Disclaimer: The information provided in this article is for educational and scientific communication purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider regarding any medical condition, diagnosis, or treatment plan.*
